ticlopidinehttp://www.unboundmedicine.com/medline/ebm/research/ticlopidineUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.Comparison of the pharmacokinetics of ticlopidine between administration of a combined fixed-dose tablet formulation of ticlopidine 250 mg/Ginkgo extract 80 mg, and concomitant administration of ticlopidine 250-mg and ginkgo extract 80-mg tablets: An open-label, two-treatment, single-dose, randomized-sequence crossover study in healthy Korean male volunteers.http://www.unboundmedicine.com/medline/ebm/record/19922896/full_citation/Comparison_of_the_pharmacokinetics_of_ticlopidine_between_administration_of_a_combined_fixed_dose_tablet_formulation_of_ticlopidine_250_mg/Ginkgo_extract_80_mg_and_concomitant_administration_of_ticlopidine_250_mg_and_ginkgo_extract_80_mg_tablets:_An_open_label_two_treatment_single_dose_randomized_sequence_crossover_study_in_healthy_Korean_male_volunteers_Kim TE, Kim BH, Kim J, et al. 
Comparison of the pharmacokinetics of ticlopidine between administration of a combined fixed-dose tablet formulation of ticlopidine 250 mg/Ginkgo extract 80 mg, and concomitant administration of ticlopidine 250-mg and ginkgo extract 80-mg tablets: An open-label, two-treatment, single-dose, randomized-sequence crossover study in healthy Korean male volunteers. [JOURNAL ARTICLE]
Clin Ther 2009 Oct; 31(10):2249-2257.
Abstract | Full CitationDevelopment and validation of an HPLC method for the simultaneous analysis of 23 selected drugs belonging to different therapeutic groups in human urine samples.http://www.unboundmedicine.com/medline/ebm/record/19907087/full_citation/Development_and_validation_of_an_HPLC_method_for_the_simultaneous_analysis_of_23_selected_drugs_belonging_to_different_therapeutic_groups_in_human_urine_samples_Baranowska I, Markowski P, Baranowski J 
Development and validation of an HPLC method for the simultaneous analysis of 23 selected drugs belonging to different therapeutic groups in human urine samples. [Journal Article, Research Support, Non-U.S. Gov't]
Anal Sci 2009 Nov; 25(11):1307-13.
Abstract | Full Citation | Find Related Articles P2Y12 inhibitors.http://www.unboundmedicine.com/medline/ebm/record/19882081/full_citation/P2Y12_inhibitors_Collet JP, Montalescot G 
P2Y12 inhibitors. [Journal Article]
Hamostaseologie 2009 Sep; 29(4):339-48.
Abstract | Full Citation | Find Related Articles Cilostazol reduces restenosis after carotid artery stenting.http://www.unboundmedicine.com/medline/ebm/record/19879096/full_citation/Cilostazol_reduces_restenosis_after_carotid_artery_stenting_Takigawa T, Matsumaru Y, Hayakawa M, et al. 
Cilostazol reduces restenosis after carotid artery stenting. [JOURNAL ARTICLE]
J Vasc Surg 2009 Oct 29.
Abstract | Full Citation | Publisher Full Text | Find Related Articles Effects of cytochrome P450 inhibitors on the biotransformation of fluorogenic substrates by adult male rat liver microsomes and cDNA-expressed rat cytochrome P450 isoforms.http://www.unboundmedicine.com/medline/ebm/record/19858067/full_citation/Effects_of_cytochrome_P450_inhibitors_on_the_biotransformation_of_fluorogenic_substrates_by_adult_male_rat_liver_microsomes_and_cDNA_expressed_rat_cytochrome_P450_isoforms_Makaji E, Trambitas CS, Shen P, et al. 
Effects of cytochrome P450 inhibitors on the biotransformation of fluorogenic substrates by adult male rat liver microsomes and cDNA-expressed rat cytochrome P450 isoforms. [JOURNAL ARTICLE]
Toxicol Sci 2009 Oct 25.
Abstract | Full Citation | Publisher Full Text | Find Related Articles [Basic examination before clinical examination. That is why it is worthwhile to return to the laboratory]http://www.unboundmedicine.com/medline/ebm/record/19852089/full_citation/[Basic_examination_before_clinical_examination__That_is_why_it_is_worthwhile_to_return_to_the_laboratory]Kuliczkowski W 
[Basic examination before clinical examination. That is why it is worthwhile to return to the laboratory] [Journal Article]
Kardiol Pol 2009 Jun; 67(6):599-600.
Full Citation | Find Related Articles Antiplatelet Treatment in Ischemic Stroke Treatment.http://www.unboundmedicine.com/medline/ebm/record/19849660/full_citation/Antiplatelet_Treatment_in_Ischemic_Stroke_Treatment_Pinto A, Di Raimondo D, Tuttolomondo A, et al. 
Antiplatelet Treatment in Ischemic Stroke Treatment. [JOURNAL ARTICLE]
Curr Top Med Chem 2009 Oct 22.
Abstract | Full Citation | Find Related Articles [Thienopyridines in the Treatment and Prevention of Cardiovascular Diseases. Part II. Clinical Pharmacology of Clopidogrel.]http://www.unboundmedicine.com/medline/ebm/record/19845526/full_citation/[Thienopyridines_in_the_Treatment_and_Prevention_of_Cardiovascular_Diseases__Part_II__Clinical_Pharmacology_of_Clopidogrel_]Preobrazhenskii DV, Sidorenko BA, Batyraliev TA, et al. 
[Thienopyridines in the Treatment and Prevention of Cardiovascular Diseases. Part II. Clinical Pharmacology of Clopidogrel.] [English Abstract, Journal Article]
Kardiologiia 2009; 49(10):88-96.
Abstract | Full CitationComparison of mechanism-based inhibition of human cytochrome P450 2C19 by ticlopidine, clopidogrel, and prasugrel.http://www.unboundmedicine.com/medline/ebm/record/19845434/full_citation/Comparison_of_mechanism_based_inhibition_of_human_cytochrome_P450_2C19_by_ticlopidine_clopidogrel_and_prasugrel_Nishiya Y, Hagihara K, Kurihara A, et al. 
Comparison of mechanism-based inhibition of human cytochrome P450 2C19 by ticlopidine, clopidogrel, and prasugrel. [Journal Article]
Xenobiotica 2009 Nov; 39(11):836-43.
Abstract | Full Citation | Find Related Articles Routine early angioplasty after fibrinolysis.http://www.unboundmedicine.com/medline/ebm/record/19824131/full_citation/Routine_early_angioplasty_after_fibrinolysis_Wang Z, Liang B, Mei Q 
Routine early angioplasty after fibrinolysis. [Comment, Letter]
N Engl J Med 2009 Oct 8; 361(15):1509; author reply 1509-10.
Full Citation | Find Related Articles